Our second major line of research aims to
understand axonal pathology in SMA, an autosomal recessive neuromuscular disease.
Richard T. Libby, PhD University of Rochester Medical School, Rochester, NY Funded by The Alcon Foundation Project:
Understanding Axonal Degeneration Pathways in Glaucoma
Not exact matches
Hayashi and Niwa expect the non-invasive force measurement method to be a strong, new tool in
understanding the physical mechanism of neuronal diseases caused by deficits in
axonal transport.
This suggests that
understanding the role of dysregulated miRNA in mDA neurons may provide insights into the pathophysiological mechanisms of mDA
axonal degeneration in PD, and provide new opportunities for mDA
axonal protection or re-growth.
Therefore
understanding the dysfunctional molecular pathways that cause mDA
axonal degeneration, and targeting these to protect or re-grow mDA axons, may be a promising therapeutic approach for PD.
Dominant mutations in the MORC2 gene have recently been shown to cause
axonal Charcot - Marie - Tooth (CMT) disease, but the cellular function of MORC2 is poorly
understood.